Soergel David Insider Trades

Insider Trading History

Track insider trading activity for Soergel David. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals MDGL
Chief Medical Officer
Holding Value $5.41M 11,075 shares
Last Trade
May 18, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$435k 844 shares
$515.90
$488.15
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals MDGL
Chief Medical Officer
Holding Value $5.82M 11,919 shares
Last Trade
Mar 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.28M 9,841 shares
$434.80
$488.15
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals MDGL
Chief Medical Officer
Holding Value $6.27M 12,839 shares
Last Trade
May 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.75M 12,839 shares
$291.82
$488.15
Trevena
Trevena TRVN
Sr. Vp,clinical Dev. & CMO
Holding Value $91 91,000 shares
Last Trade
Mar 02, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$235M 91,000 shares
$2,581.25
$0.00
Trevena
Trevena TRVN
Sr. Vp,clinical Dev. & CMO
Holding Value $55 55,000 shares
Last Trade
Jan 06, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$227M 55,000 shares
$4,131.25
$0.00
Trevena
Trevena TRVN
Sr. Vp,clinical Dev. & CMO
Holding Value $105 105,000 shares
Last Trade
Mar 03, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$579M 105,000 shares
$5,512.50
$0.00
Trevena
Trevena TRVN
Sr. Vp,clinical Dev. & CMO
Holding Value $1.75 1,750 shares
Last Trade
Dec 10, 2015 Sale (Open Market)Shares sold on the open market or in a private sale.
$182M 27,217 shares
$6,681.25
$0.00
Trevena
Trevena TRVN
Sr. Vp,clinical Dev. & CMO
Holding Value $87.5 87,500 shares
Last Trade
Mar 17, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$371M 87,500 shares
$4,243.75
$0.00
Trevena
Trevena TRVN
Sr. Vp, Clinical Development
Holding Value $28.5 28,467 shares
Last Trade
Dec 10, 2014 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.2M 1,250 shares
$2,556.25
$0.00
Trevena
Trevena TRVN
Sr. Vp, Clinical Development
Holding Value $29 28,967 shares
Last Trade
Dec 09, 2014 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.41M 1,750 shares
$2,518.75
$0.00
Trevena
Trevena TRVN
Sr. Vp, Clinical Development
Holding Value $55 55,000 shares
Last Trade
Feb 20, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$254M 55,000 shares
$4,625.00
$0.00
Trevena
Trevena TRVN
Sr. Vp, Clinical Development
Holding Value $27.2 27,217 shares
Last Trade
Jan 30, 2014 Sale
No data
No data
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up